Ning Zhang
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 11
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 29
- Immunology top 1%
- Immune cells in cancer 20
- Molecular Biology top 1%
- Advanced biosensing and bioanalysis techniques 25
- RNA modifications and cancer 16
- RNA Interference and Gene Delivery 16
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 15
-
- Nanoplatforms for cancer theranostics 37
- Journals
- Nature (2 papers)Journal of the American Chemical Society (1 paper)Nucleic Acids Research (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ning Zhang
313 papers receiving 11.1k citations
Hit Papers
Peers
Comparison fields: 5 of 186
- Cancer Research 1.9k
- Biomaterials 1.3k
- Immunology 1.9k
- Molecular Biology 5.3k
- Oncology 1.9k
Countries citing papers authored by Ning Zhang
This map shows the geographic impact of Ning Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Zhang more than expected).
Fields of papers citing papers by Ning Zhang
This network shows the impact of papers produced by Ning Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Zhang. The network helps show where Ning Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ning Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 9 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 14 | |
| 10 | 2023 | 5 | |
| 11 | 2021 | 63 | |
| 12 | 2020 | 58 | |
| 13 | 2019 | 8 | |
| 14 | 2019 | 16 | |
| 15 | 2018 | 2 | |
| 16 | 2018 | 35 | |
| 17 | 2017 | 153 | |
| 18 | 2010 | 105 | |
| 19 | 2009 | 57 | |
| 20 | 2008 | 275 |
About Ning Zhang
Ning Zhang is a scholar working on Immunology, Biomaterials and Cancer Research, having authored 327 papers that have together received 11.2k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (37 papers), Nanoparticle-Based Drug Delivery (29 papers), Advanced biosensing and bioanalysis techniques (25 papers), Immune cells in cancer (20 papers), RNA modifications and cancer (16 papers), RNA Interference and Gene Delivery (16 papers), Cancer Immunotherapy and Biomarkers (15 papers) and Cancer Genomics and Diagnostics (11 papers). The work is most often cited by research in Cancer Research (1.9k citations), Biomaterials (1.3k citations) and Immunology (1.9k citations). Ning Zhang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Weishan Chen, Shengjie Xu, Ying Yin, Hua Guo, Joost J. Oppenheim, Yinsong Wang, Ping Zhou, Ruidong Xue, Kevin P. Francis and Ruirui Kong. Their work appears in journals such as Nature, Journal of the American Chemical Society and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.